Advertisement

Topics

Baxter completes acquisition of Claris Injectables for nearly $625m

19:00 EDT 30 Jul 2017 | Pharmaceutical Technology

US-based medical products company Baxter International has completed the acquisition of Claris Injectables, a global generic injectables pharmaceutical company, for a total consideration of approximately $625m.

Original Article: Baxter completes acquisition of Claris Injectables for nearly $625m

NEXT ARTICLE

More From BioPortfolio on "Baxter completes acquisition of Claris Injectables for nearly $625m"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...